These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24203313)

  • 1. Influence of descriptive terminology on management of atypical thyroid fine-needle aspirates.
    Vivero M; Renshaw AA; Krane JF
    Cancer Cytopathol; 2014 Mar; 122(3):175-81. PubMed ID: 24203313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young investigator challenge: Atypia of undetermined significance in thyroid FNA: Standardized terminology without standardized management--a closer look at repeat FNA and quality measures.
    Brandler TC; Aziz MS; Coutsouvelis C; Rosen L; Rafael OC; Souza F; Jelloul FZ; Klein MA
    Cancer Cytopathol; 2016 Jan; 124(1):37-43. PubMed ID: 26765064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
    Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
    Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular lesion of undetermined significance in thyroid FNA revisited.
    Walts AE; Mirocha J; Bose S
    Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the malignancy risk for atypia of undetermined significance? Three years' experience at a university hospital in Turkey.
    Gocun PU; Karakus E; Bulutay P; Akturk M; Akin M; Poyraz A
    Cancer Cytopathol; 2014 Aug; 122(8):604-10. PubMed ID: 24890894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.
    Ozluk Y; Pehlivan E; Gulluoglu MG; Poyanli A; Salmaslioglu A; Colak N; Kapran Y; Yilmazbayhan D
    Int J Surg Pathol; 2011 Dec; 19(6):761-71. PubMed ID: 21791482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?
    VanderLaan PA; Marqusee E; Krane JF
    Am J Clin Pathol; 2011 May; 135(5):770-5. PubMed ID: 21502433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
    Singh RS; Wang HH
    Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.
    Broome JT; Solorzano CC
    Surgery; 2011 Dec; 150(6):1234-41. PubMed ID: 22136846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
    Wu HH; Rose C; Elsheikh TM
    Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance.
    VanderLaan PA; Marqusee E; Krane JF
    Am J Clin Pathol; 2011 Oct; 136(4):572-7. PubMed ID: 21917679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should atypia of undetermined significance be subclassified to better estimate risk of thyroid cancer?
    Chen JC; Pace SC; Khiyami A; McHenry CR
    Am J Surg; 2014 Mar; 207(3):331-6; discussion 335-6. PubMed ID: 24581759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bethesda System for Reporting Thyroid Fine-Needle Aspiration Cytology: A Kuwaiti Experience - A Cytohistopathological Study of 374 Cases.
    Kapila K; Qadan L; Ali RH; Jaragh M; George SS; Haji BE
    Acta Cytol; 2015; 59(2):133-8. PubMed ID: 25676743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
    Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
    Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe.
    Cochand-Priollet B; Schmitt FC; Tötsch M; Vielh P;
    Acta Cytol; 2011; 55(6):507-11. PubMed ID: 22156458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
    Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
    Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.